RAC 0.00% $1.66 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-200

  1. 8,506 Posts.
    lightbulb Created with Sketch. 1397
    Bisantrene is less potent only on the non-tumourigenic line MCF10A.

    I can live with that.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.